[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566611":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":34,"collaborators":10,"id":36,"slug":10,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":10,"eligibilityCriteria":40,"healthyVolunteers":37,"sex":41,"minAge":42,"maxAge":10,"enrollmentInfo":43,"targetDuration":10,"studyType":46,"phases":10,"briefSummary":47,"conditions":48,"keywords":54,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Shanghai Mental Health Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients and their caregivers",null,"Patients (and their caregivers) with psychiatric disorders for which risperidone is indicated, including schizophrenia, bipolar disorder, autism spectrum disorder, conduct disorder, and mental retardation.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Lan Luo, Doctor of Medicine","CONTACT","+8618516544150","lan-luo@foxmail.com",[19],{"facility":5,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"RECRUITING","Shanghai","Shanghai Municipality","200030","China","CN",{"type":27,"coordinates":28},"Point",[29,30],121.45806,31.22222,{"lat":30,"lon":29},[33],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},{"type":35,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100566611",false,"NCT06657430","A Study on the Preference of Risperidone Dosage Forms","Inclusion Criteria:\n\n* Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.\n\nExclusion Criteria:\n\n* Have difficulty reading and understanding Chinese or refuse to participate in the study.","ALL","18 Years",{"count":44,"type":45},1000,"ESTIMATED","OBSERVATIONAL","This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.",[49,50,51,52,53],"Schizophrenia","Bipolar Affective Disorder","Autism Spectrum Disorder","Conduct Disorder","Mental Retardation",[55,56,57,58],"risperidone","patch","cross-sectional study","preference","2024-10-23",{"date":61,"type":62},"2024-10-24","ACTUAL",{"date":64,"type":62},"2024-09-19",{"date":66,"type":45},"2025-02-28",{"name":5,"class":6},1]